Show simple item record

dc.contributor.authorBesser, R.en
dc.contributor.authorShields, Beverleyen
dc.contributor.authorHammersley, S.en
dc.contributor.authorColclough, Kevinen
dc.contributor.authorMcDonald, Timothy J.en
dc.contributor.authorGray, Z.en
dc.contributor.authorHeywood, J. J. N.en
dc.contributor.authorBarrett, T. G.en
dc.contributor.authorHattersley, Andrew T.en
dc.identifier.citationHome urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. 2013, 14 (3):181-8 Pediatr Diabetesen
dc.description.abstractMaking the correct diabetes diagnosis in children is crucial for lifelong management. Type 2 diabetes and maturity onset diabetes of the young (MODY) are seen in the pediatric setting, and can be difficult to discriminate from type 1 diabetes. Postprandial urinary C-peptide creatinine ratio (UCPCR) is a non-invasive measure of endogenous insulin secretion that has not been tested as a diagnostic tool in children or in patients with diabetes duration <5 yr. We aimed to assess whether UCPCR can discriminate type 1 diabetes from MODY and type 2 in pediatric diabetes.en
dc.rightsArchived with thanks to Pediatric diabetesen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleHome urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes.en
dc.typeMulticenter Studyen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.identifier.journalPediatric diabetesen
dc.description.noteThis article is freely available via Open Access. Click on the 'Additional Link' above to access the full-text from the publisher's site.en
dc.description.fundingG0800661/Medical Research Council/United Kingdom NIHR-HCS-P12-03-03/Department of Health/United Kingdomen

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record